Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from TATA Health International Holdings Ltd. ( (HK:1255) ).
TATA Health International Holdings Ltd. has executed a deed of assignment involving Sigma, CHH and director Mr. Zhang, under which the company reassigned portions of a loan owed by associate CHH to settle its own indebtedness of about HK$7.38 million to Sigma and HK$21.94 million to Mr. Zhang on a dollar-for-dollar basis. Following completion, these amounts are now owed directly by CHH to Sigma and Mr. Zhang, and the transaction is classified as both a major and connected transaction under Hong Kong Listing Rules, triggering requirements for disclosure, shareholder approval and independent oversight due to the involvement of a director and a substantial shareholder.
More about TATA Health International Holdings Ltd.
TATA Health International Holdings Ltd., incorporated in the Cayman Islands and listed in Hong Kong, operates through investments and loan arrangements with associates, reflecting a focus on financial structuring within its group. The company’s dealings with connected parties and substantial shareholders place it under close scrutiny of Hong Kong’s Listing Rules and related-party transaction regulations.
Average Trading Volume: 643,112
Technical Sentiment Signal: Buy
Current Market Cap: HK$364.3M
Learn more about 1255 stock on TipRanks’ Stock Analysis page.